Viatris
Provides access to medicines, advances sustainable operations, develops innovative solutions and leverages collective expertise to connect more people to more products.
Launch date
Employees
Market cap
€12.8b
Enterprise valuation
€27.5b (Public information from Sep 2024)
Share price
$11.9 VTRS
Canonsburg Pennsylvania (HQ)
Financials
Estimates*
USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 11.9b | 17.9b | 16.3b | 15.4b | 14.9b | 14.6b | 14.7b |
% growth | 4 % | 50 % | (9 %) | (5 %) | (3 %) | (2 %) | - |
EBITDA | 2.1b | 301m | 3.4b | 3.7b | 4.7b | 4.6b | 4.7b |
% EBITDA margin | 18 % | 2 % | 21 % | 24 % | 32 % | 32 % | 32 % |
Profit | (670m) | (1.3b) | 2.1b | 54.7m | 1.5b | 667m | 784m |
% profit margin | (6 %) | (7 %) | 13 % | - | 10 % | 5 % | 5 % |
EV / revenue | 4.0x | 2.2x | 0.8x | 1.9x | 1.8x | 1.8x | 1.6x |
EV / EBITDA | 22.6x | 128.7x | 3.9x | 8.1x | 5.7x | 5.5x | 5.1x |
R&D budget | 555m | 751m | 662m | 805m | - | - | - |
R&D % of revenue | 5 % | 4 % | 4 % | 5 % | - | - | - |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | N/A | IPO | |
* | N/A | Merger | |
Total Funding | - |
Related Content
Recent News about Viatris
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Viatris
EditACQUISITION by Viatris Mar 2016
ACQUISITION by Viatris Aug 2006
ACQUISITION by Viatris Aug 2006
ACQUISITION by Viatris Dec 2022
ACQUISITION by Viatris May 2016
ACQUISITION by Viatris Dec 2022